CHINA PHARMA HOLDINGS, INC. — Form D
CHINA PHARMA HOLDINGS, INC. of HAIKOU, F4, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-29. The offering totals $5.3M, of which $5.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2021-11-29
- Form: D
- Accession: 0001213900-21-062343
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.3M
- Amount sold: $5.3M
- Investors: 1
- Date of first sale: 2021-11-17
- Security types: debt
- Revenue range: $5,000,001 - $25,000,000
- SEC file number: 021-422728
Issuer
- Name: CHINA PHARMA HOLDINGS, INC.
- CIK: 0001106644
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: SECOND FLOOR, NO. 17, JINPAN ROAD, HAIKOU, F4, 570216
- Phone: +86-898-6681-1730
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Gene Michael Bennett | Director | HAIKOU, F4 |
| Baowen Michael Dong | Director | HAIKOU, F4 |
| Zhilin Li | Director | HAIKOU, F4 |
| Heung Mei Tsui | Director | HAIKOU, F4 |
| Yingwen Michael Zhang | Director | HAIKOU, F4 |
| Zhilin Li | Executive Officer | HAIKOU, F4 |
More